<DOC>
	<DOCNO>NCT02288910</DOCNO>
	<brief_summary>This project investigate feasibility assess relative blood volume carcinoma patient Hepatocellular Carcinoma ( HCC ) liver metastases pancreatic colorectal cancer compare normal liver DynaCT acquisition interventional platform .</brief_summary>
	<brief_title>Blood Volume Assessment Hepatocellular Metastatic Carcinomas Liver</brief_title>
	<detailed_description>This project enroll patient non-diffuse liver disease candidate chemo radioembolization treat manage disease image guide intervention . Subjects undergo CT perfusion study liver prior radioembolizaiton mapping procedure prior chemoembolization treatment . During radioembolization map chemoembolization procedure , 2 DynaCT acquisition interventional C-arm acquire ( second injection iodinate contrast material ) process use Siemens ' PBV software generate blood volume map . The diagnostic accuracy two approach assess vascularity tumor assess .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>HCC metastatic liver disease Candidate radioembolization chemoembolization Pregnant Iodine allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Liver Perfusion</keyword>
	<keyword>DynaCT Perfusion</keyword>
	<keyword>Radioembolization</keyword>
	<keyword>Chemoembolization</keyword>
</DOC>